Developing a Payer Story for a New Mechanism of Action
With the oncology pipeline replete with new molecules and so much attention on checkpoint inhibitors and targeted therapies, our client was concerned that payers might have difficulty understanding their key message about a potential breakthrough therapy for a small population of high unmet need and significant disease burden. Even more challenging, we needed to package this story into fewer than ten slides with great visuals and robust evidence for every message. We aligned across stakeholders, developed and designed a deck that the payer team was excited to carry, and ensured that it met every requirement for a seamless review, revision, and approval process.
